Episode Synopsis "Unraveling the Pathophysiology of gMG and Its Impact on Treatment Selection With Drs. Nicholas Silvestri and Carolina Barnett-Tapia"

In this podcast, expert clinicians will discuss the pathophysiology of gMG and the significance of disease subtype on clinical decision-making. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/neurology/20250220/2-unraveling-the-pathophysiology-of-gmg-and-its-impact-on-treatment-selection

Listen "Unraveling the Pathophysiology of gMG and Its Impact on Treatment Selection With Drs. Nicholas Silvestri and Carolina Barnett-Tapia"

More episodes of the podcast MedEdTalks - Neurology

• Exploring the Latest Data on Targeted Therapies for Treating gMG With Drs. Nicholas Silvestri and Kelly Gwathmey
• Unraveling the Pathophysiology of gMG and Its Impact on Treatment Selection With Drs. Nicholas Silvestri and Carolina Barnett-Tapia
• Understanding Disease Burden and Severity in gMG With Drs. Nicholas Silvestri and Neelam Goyal
• Incorporating Patient-Centered Care in Treatment Decisions With Drs. Stuart Isaacson and Rajesh Pahwa
• Available and Novel Therapies for Nonmotor Symptoms in Parkinson’s Disease With Drs. Pahwa and Armstrong
• Current and Emerging Treatment Options for Motor Symptoms in Parkinson’s Disease With Drs. Rajesh Pahwa and Stuart Isaacson
• Staging and Monitoring Parkinson’s Disease With Drs. Rajesh Pahwa and David Standaert
• Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle
• Gender-based Issues in MS and the Role of Patient-Provider Communication With Dr. Patricia K. Coyle and Dana Hernandez
• Progressive MS: Selecting Optimal Treatments, With Patricia K. Coyle, MD, FAAN, FANA; and Clyde E. Markowitz, MD
• Relapsing MS: Improving Patient Recognition With Patricia K. Coyle, MD, FAAN, FANA; and Stephen Krieger, MD, FAAN
• MS and the Family Planning Process: Opening Up the Discussion, With Patricia Melville and Patricia K. Coyle, MD, FAAN, FANA
• Current and Emerging Agents: Applying the Latest Evidence With Patricia K. Coyle, MD, FAAN, FANA; and Clyde E. Markowitz, MD
• MS Care During a Pandemic: COVID-19 and Telehealth, With Patricia K. Coyle, MD, FAAN, FANA; and Stephen Krieger, MD, FAAN
• The Future Treatment Landscape of Alzheimer’s Disease With Drs. Raymond Scott Turner and Marwan Noel Sabbagh
• Current Therapies for Alzheimer’s Disease With Drs. Raymond Scott Turner and Marwan Noel Sabbagh
• Understanding the Pathophysiology of Alzheimer’s Disease With Drs. Raymond Scott Turner and Sharon Cohen
• The Critical Importance of Early Diagnosis of Alzheimer’s Disease With Drs. Raymond Scott Turner and Sharon Cohen
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Long-term Outcomes with Established Therapies
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Immune Reconstitution
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Shared Decision-making
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- S1P Receptor Modulators in RRMS
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- MS in Pregnancy
• MS Forum® VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care -- Monoclonals in Progressive MS
• MedEd Talks in Neurology - MS Forum VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality Care